OB/ PHARM | Betamethasone

https://statstitch.etsy.com

Betamethasone is a synthetic glucocorticoid utilized primarily for its anti-inflammatory and immunosuppressive properties. It is available in systemic forms (injectable and oral) and topical formulations, which range from medium potency, such as betamethasone valerate, to high or very high potency, such as betamethasone dipropionate.

Mechanism of Action At the cellular level, betamethasone works by inducing lipocortins, which inhibit phospholipase A2. This action prevents the breakdown of lysosomal membranes and stops the release of arachidonic acid, thereby halting the production of endogenous inflammatory mediators such as prostaglandins, kinins, and histamine. This blocks early inflammatory processes like vascular permeability and leukocyte movement, as well as later processes like collagen deposition and scar formation, ultimately resulting in decreased swelling, redness, itching, and scaling of the skin.

Pharmacokinetics and Absorption The drug can be administered orally, topically, or via multiple injection routes (intramuscular, intravenous, intra-articular, etc.). Systemically absorbed betamethasone is metabolized by the CYP3A4 enzyme, binds weakly to plasma proteins, and has a biological half-life of 35 to 54 hours. For topical applications, systemic absorption increases dramatically if the skin is damaged, inflamed, occluded, or naturally thin (such as on the eyelids, face, or genitalia). Once absorbed through the skin, topical corticosteroids enter the exact same pharmacokinetic pathways as systemically administered forms.

Key Adverse Reactions Betamethasone carries an extensive risk profile, especially with prolonged use or high systemic absorption.

• Severe Reactions: Notable severe risks include skin atrophy (occurring in up to 33% of cases), increased intracranial pressure, bone fractures, avascular necrosis, gastrointestinal perforation, and severe cardiovascular issues like heart failure, myocardial infarction, or stroke.
• Moderate Reactions: The highest-frequency moderate risk is hypothalamic-pituitary-adrenal (HPA) axis suppression, which occurs in up to 73% of cases. Other significant moderate risks include Cushing's syndrome, hyperglycemia, immunosuppression, and osteoporosis.
• Mild Reactions: Localized issues such as pruritus, maculopapular rash, skin irritation, and xerosis occur in 1-10% of users.

Pregnancy and Lactation Guidelines

• Pregnancy: Use requires extreme caution. Systemic use has been associated with cleft palate, stillbirth, and premature abortion. While it is sometimes used off-label to induce fetal lung maturation in preterm birth scenarios, chronic use is discouraged. Pregnant women should avoid using potent topical steroids in large amounts; using over 300 grams of potent topical corticosteroids in the third trimester significantly increases the risk of fetal growth restriction and low birth weight.
• Lactation: The drug is excreted in breast milk and could theoretically suppress infant growth or natural corticosteroid production, but oral use is still generally considered acceptable during breastfeeding. Topical use is also deemed safe by dermatologists, provided extreme care is taken to ensure the infant does not come into direct physical contact with the applied area.